← Open Payments lookup

MARLEE BOGEMA: Open Payments

NPI 1396398236 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,207 in 111 payments from 33 companies in 2025. Trend: 2023 $2,585 · 2024 $3,278 · 2025 $8,207

Consulting: $4,266Food & beverage: $2,635Travel & lodging: $1,282Education: $23
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.20$4,239
Janssen Biotech, Inc.3$1,212
E.R. Squibb & Sons, L.L.C.3$405
AstraZeneca Pharmaceuticals LP7$251
GENZYME CORPORATION6$249
Amgen Inc.2$221
Novartis Pharmaceuticals Corporation16$186
Rigel Pharmaceuticals, Inc.3$168
Syndax Pharmaceuticals, Inc.3$165
Merck Sharp & Dohme LLC5$142

Products named: LYNOZYFIC, TALVEY, IMFINZI, KISQALI, REVUFORJ, WAYRILZ, BREYANZI, REZLIDHIA.

Industry payments across MI — which companies pay providers there.